Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2207955
Max Phase: Preclinical
Molecular Formula: C19H13N3S
Molecular Weight: 315.40
Molecule Type: Small molecule
Associated Items:
ID: ALA2207955
Max Phase: Preclinical
Molecular Formula: C19H13N3S
Molecular Weight: 315.40
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1ccc(C2=C/C(=C\C#N)N3C(=N2)Sc2ccccc23)cc1
Standard InChI: InChI=1S/C19H13N3S/c1-13-6-8-14(9-7-13)16-12-15(10-11-20)22-17-4-2-3-5-18(17)23-19(22)21-16/h2-10,12H,1H3/b15-10+
Standard InChI Key: ISBONGPRSZGVKV-XNTDXEJSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 315.40 | Molecular Weight (Monoisotopic): 315.0830 | AlogP: 4.73 | #Rotatable Bonds: 1 |
Polar Surface Area: 39.39 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 2.06 | CX LogP: 4.35 | CX LogD: 4.35 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.71 | Np Likeness Score: -0.73 |
1. Patil VS, Nandre KP, Ghosh S, Rao VJ, Chopade BA, Bhosale SV, Bhosale SV.. (2012) Synthesis and glycosidase inhibitory activity of novel (2-phenyl-4H-benzopyrimedo[2,1-b]-thiazol-4-yliden)acetonitrile derivatives., 22 (23): [PMID:23102653] [10.1016/j.bmcl.2012.10.025] |
Source(1):